Varifarma’s commitment to PORTFOLIO DEVELOPMENT and CONTINUOUS QUALITY IMPROVEMENT has propelled the company toward exceptional and unceasing growth. We are constantly DRIVEN BY NEW CHALLENGES that strengthen our path toward the future.
the medical and scientific communities, as well as for our focus on innovation and the continuous improvement of our production areas and processes. These are supported by rigorous control procedures that meet the highest national and international quality standards.
product registrations worldwide
product registrations across LATAM
CMC Pharma Solutions and Laboratorio Varifarma Announce Their Strategic Partnership Across Latin America and Europe
An Expert Presentation Addressed the Value of FOSTAX® for Adult Patients With Chronic Immune Thrombocytopenia
Varifarma Hosted a Scientific Symposium on GORAX® for Advanced Prostate Cancer
Varifarma Peru Reinforces Its Commitment to Regional Growth and Continuous Training
A Dedicated Launch Event Bringing Together Specialists in Urologic Oncology
Innovation and sustained efficacy in ALK-positive lung cancer.
A key gathering for specialists reinforcing our therapeutic commitment to PAH.
